M&A/Shareholder vote/2026/Impact BioMedical Inc.

Impact BioMedical Inc. IBO

Zoar Limited (f.k.a Dr Ashleys Limited) is buying Impact BioMedical Inc. (IBO), paying holders in stock.

Holders get
Stock
such number of ordinary shares of PubCo representing 4.80% of the total issued and outstanding PubCo Shares at the closing of the Business Combination, on a pro rata basis
Deal value
Not given
Expected close
Not given
Status
Pending
Checked
See the filing →

Filed

What has happened

Agreement signed · See the filing
Terms changed · The merger agreement was amended to add share issuances to DSS, Inc. and extend the End Date from March 31, 2026 to July 1, 2026. · See the filing
Holders sent the terms and a meeting date

What must happen first

adoption of the Merger and Share Exchange Agreement by requisite stockholders
absence of law or order prohibiting consummation
NYSE approval of PubCo Shares listing
Impact having net cash of at least $10,000 at Closing

The board says

FOR the adoption of the Business Combination Proposal